Mednet Logo

Do you extend biologic dosing intervals in a patient with moderate-to-severe psoriasis who has achieved and maintained PASI 100 for at least one year?

Does your decision change based on class of biologic or do you apply the same approach regardless of class?
Community PollStarted

Do you extend biologic dosing intervals in a patient with moderate-to-severe psoriasis who has achieved and maintained PASI 100 for at least one year?

45 physicians have voted

Join Mednetto vote and see how they answered.